Polypeptides

Details for Australian Patent Application No. 2007211889 (hide)

Owner GemVax AS

Inventors Eriksen, Hon Amund; Saeboe-Larssen, Stein; Gaudernack, Gustav; Moller, Mona

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007211889

Parent 2002216477

Filing date 22 August 2007

Wipo publication date 13 September 2007

Acceptance publication date 19 November 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

6 September 2007 Complete Application Filed

13 September 2007 Application Open to Public Inspection

  Published as AU-B-2007211889

19 November 2009 Application Accepted

  Published as AU-B-2007211889

10 December 2009 Corrigenda

  Applications Accepted - Name Index Under the name GemVax AS, Application No. 2007211889, Under INID (72), correct the co-inventor to read Eriksen, Jon Amund

18 February 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 02 Feb 2010. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

10 June 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Feb 2010

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007211890-A method of treating a malignancy in a subject and a pharmaceutical composition for use in same

2007211888-Method for composition for rejuvinating cells, tissues organs, hair and nails